KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News Podcast
May 27, 2025
American Hospital Association Senior VP of Public Policy Analysis and Development Ashley Thompson joins the KHA podcast to talk about the AHA's new 'Cost of Caring' study.
News
May 26, 2025
At the 21st Annual Best Places to Work in Kentucky awards ceremony on May 22, over 1,000 attendees celebrated the 100 recognized Kentucky companies for their dedication to improving workplace environments.
News
May 23, 2025
The Medicaid program serves nearly one-third of the patients in Kentucky and is crucial to access to timely health care everywhere in the state.